Asset Allocation

As of February 28, 2026.
Type % Net
Cash 18.95%
Stock 68.25%
Bond 8.68%
Convertible 0.00%
Preferred 0.00%
Other 4.11%
View Asset Allocation
Start Trial

Market Capitalization

As of February 28, 2026
Large 0.31%
Mid 6.71%
Small 92.98%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 76.23%    % Emerging Markets: 0.00%    % Unidentified Markets: 23.77%

Americas 73.93%
72.63%
Canada 0.02%
United States 72.61%
1.30%
As of February 28, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.24%
United Kingdom 1.78%
0.46%
France 0.05%
Ireland 0.24%
Netherlands 0.00%
Sweden 0.16%
Switzerland 0.00%
0.00%
0.00%
Greater Asia 0.06%
Japan 0.02%
0.03%
Australia 0.03%
0.02%
Singapore 0.00%
South Korea 0.02%
0.00%
Unidentified Region 23.77%

Bond Credit Quality Exposure

AAA 18.90%
AA 5.32%
A 5.33%
BBB 10.15%
BB 2.25%
B 0.46%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.74%
Not Available 55.84%
Short Term 0.00%
As of February 28, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
33.56%
Materials
5.24%
Consumer Discretionary
9.83%
Financials
12.87%
Real Estate
5.62%
Sensitive
40.54%
Communication Services
1.34%
Energy
4.08%
Industrials
22.44%
Information Technology
12.68%
Defensive
14.58%
Consumer Staples
4.01%
Health Care
7.67%
Utilities
2.90%
Not Classified
11.31%
Non Classified Equity
0.59%
Not Classified - Non Equity
10.72%
As of February 28, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of February 28, 2026
Type % Net
Government 44.46%
Corporate 13.60%
Securitized 40.02%
Municipal 0.00%
Other 1.92%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
47.04%
Less than 1 Year
47.04%
Intermediate
15.59%
1 to 3 Years
7.13%
3 to 5 Years
5.33%
5 to 10 Years
3.12%
Long Term
37.05%
10 to 20 Years
14.05%
20 to 30 Years
12.96%
Over 30 Years
10.04%
Other
0.32%
As of February 28, 2026
View Bond Maturity Exposure
Start Trial